Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Scientific Reports|October 9, 2015
Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responsesJunko Matsuzaki, Takemasa Tsuji, Immanuel F Luescher, et al.Cancer Research|December 30, 2011
CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1Julien Fourcade, Zhaojun Sun, Ornella Pagliano, et al.The Journal of Biological Chemistry|June 27, 2008
Increased mobility of major histocompatibility complex I-peptide complexes decreases the sensitivity of antigen recognitionJean-Manuel Segura, Philippe Guillaume, Silke Mark, et al.The Journal of Biological Chemistry|April 5, 2005
CD8+ cytotoxic T lymphocyte activation by soluble major histocompatibility complex-peptide dimersMarek Cebecauer, Philippe Guillaume, Silke Mark, et al.Journal of Molecular Biology|November 10, 2019
CD8 Binding of MHC-Peptide Complexes in cis or trans Regulates CD8<sup>+</sup> T-cell ResponsesYang Liu, Michel A Cuendet, Laurence Goffin, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 14, 2011
Basal and antigen-induced exposure of the proline-rich sequence in CD3εJavier de la Cruz, Travis Kruger, Christopher A Parks, et al.Cancer Research|October 8, 2009
Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterpartsCamilla Jandus, Gilles Bioley, Danijel Dojcinovic, et al.The Journal of Biological Chemistry|October 24, 2012
Cholesterol and sphingomyelin drive ligand-independent T-cell antigen receptor nanoclusteringEszter Molnár, Mahima Swamy, Martin Holzer, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patientsJulien Fourcade, Pavol Kudela, Zhaojun Sun, et al.The Journal of Biological Chemistry|April 12, 2003
The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activationMarie-Agnès Doucey, Daniel F Legler, Mustapha Faroudi, et al.Pageof 5